{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:43:21Z","timestamp":1791287001611,"version":"4.1.0"},"reference-count":37,"publisher":"American Society for Microbiology","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Brequinar is an inhibitor of dihydroorotate dehydrogenase, an enzyme that is required for\n                    <jats:italic>de novo<\/jats:italic>\n                    pyrimidine biosynthesis. Here we report that brequinar has activity against a broad spectrum of viruses. The compound not only inhibits flaviviruses (dengue virus, West Nile virus, yellow fever virus, and Powassan virus) but also suppresses a plus-strand RNA alphavirus (Western equine encephalitis virus) and a negative-strand RNA rhabdovirus (vesicular stomatitis virus). Using dengue virus serotype 2 (DENV-2) as a model, we found that brequinar suppressed the viral infection cycle mainly at the step of RNA synthesis. Supplementing the culture medium with pyrimidines (cytidine or uridine) but not purines (adenine or guanine) could be used to reverse the inhibitory effect of the compound. Continuous culturing of DENV-2 in the presence of brequinar generated viruses that were partially resistant to the inhibitor. Sequencing of the resistant viruses revealed two amino acid mutations: one mutation (M260V) located at a helix in the domain II of the viral envelope protein and another mutation (E802Q) located at the priming loop of the nonstructural protein 5 (NS5) polymerase domain. Functional analysis of the mutations suggests that the NS5 mutation exerts resistance through enhancement of polymerase activity. The envelope protein mutation reduced the efficiency of virion assembly\/release; however, the mutant virus became less sensitive to brequinar inhibition at the step of virion assembly\/release. Taken together, the results indicate that (i) brequinar blocks DENV RNA synthesis through depletion of intracellular pyrimidine pools and (ii) the compound may also exert its antiviral activity through inhibition of virion assembly\/release.\n                  <\/jats:p>","DOI":"10.1128\/aac.00561-10","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T22:37:20Z","timestamp":1278455840000},"page":"3686-3695","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":109,"title":["Characterization of Dengue Virus Resistance to Brequinar in Cell Culture"],"prefix":"10.1128","volume":"54","author":[{"given":"Min","family":"Qing","sequence":"first","affiliation":[{"name":"Novartis Institute for Tropical Diseases, Singapore 138670, Singapore"},{"name":"State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zou","sequence":"additional","affiliation":[{"name":"Novartis Institute for Tropical Diseases, Singapore 138670, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yin","family":"Wang","sequence":"additional","affiliation":[{"name":"Novartis Institute for Tropical Diseases, Singapore 138670, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao Ying","family":"Xu","sequence":"additional","affiliation":[{"name":"Novartis Institute for Tropical Diseases, Singapore 138670, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Dong","sequence":"additional","affiliation":[{"name":"Novartis Institute for Tropical Diseases, Singapore 138670, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Yuan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Science, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[{"name":"Novartis Institute for Tropical Diseases, Singapore 138670, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104248200"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.9.1.41"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400460200"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/82191"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/21.11.2757"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.4.2034-2042.1993"},{"key":"e_1_3_2_8_2","first-page":"3","volume":"13","year":"2008","unstructured":"Foster, G., and P. Mathurin. 2008. Hepatitis C virus therapy to date. Antivir. Ther.13(Suppl. 1):3-8.","journal-title":"Antivir. Ther."},{"key":"e_1_3_2_9_2","first-page":"1153","volume":"1","year":"2007","unstructured":"Gubler, D., G. Kuno, and L. Markoff. 2007. Flaviviruses, p. 1153-1253. In D. M. Knipe and P. M. Howley (ed.), Fields virology,vol. 1, 5th ed. Lippincott William & Wilkins, Philadelphia, PA.","journal-title":"Fields virology"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.3.1343-1350.2005"},{"key":"e_1_3_2_11_2","unstructured":"Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases. 2005"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/315847"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.10.4633-4640.2001"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.10.4773-4784.2002"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.3.1943-1947.2005"},{"key":"e_1_3_2_16_2","first-page":"1101","volume":"1","year":"2007","unstructured":"Lindenbach, B. D., H.-J. Thiel, and C. M. Rice. 2007. Flaviviridae: the virus and their replication, p. 1101-1152. In D. M. Knipe and P. M. Howley (ed.), Fields virology,vol. 1, 5th ed. Lippincott William & Wilkins, Philadelphia, PA.","journal-title":"Fields virology"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-2126(00)00077-0"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.3.1934-1942.2005"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.14.7804-7813.2003"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi001810q"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0832193100"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.13.8004-8013.2005"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2335168100"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02451-09"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2009.12.011"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1320-1329.2006"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2010.02.313"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.006874-0"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00814-06"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.34.21682"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.12.5847-5856.2002"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0067"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01148-08"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(91)90440-M"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1993.1587"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1690"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02283-06"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0907010106"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00561-10","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00561-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:05:58Z","timestamp":1645455958000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00561-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1128\/AAC.00561-10"],"URL":"https:\/\/doi.org\/10.1128\/aac.00561-10","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"2010-04-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-06-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}